United States - Re-Export of Insulin in Dosage Forms
Since 2014, United States Re-Export of Insulin in Dosage Forms jumped by 47.1% year on year. At $6,604,316 in 2019, the country was number 2 comparing other countries in Re-Export of Insulin in Dosage Forms. United Arab Emirates topped the ranking with $37,345,759.11 in 2019, -4.3% compared to 2018. United Arab Emirates witnessed the best average annual growth at +119.7% per year, while Canada witnessed the worst performance at -13.3% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 6,604,316.00 |
| 2018 | 7,175,687.00 |
| 2017 | 4,719,680.00 |
| 2016 | 2,053,396.00 |
| 2015 | 782,658.00 |
Download all data from 1991 to 2019
How does United States rank in Re-Export of Insulin in Dosage Forms?
| # | 10 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
United Arab Emirates
|
37,345,759.11 | 2019 | -4.3 % | +119.7 % | View data |
| 2 |
#2
United States
|
6,604,316.00 | 2019 | -8.0 % | +47.1 % | View data |
| 3 |
#3
Jordan
|
4,672,370.00 | 2018 | +45.3 % | NA | View data |
| 4 |
#4
Saudi Arabia
|
3,443,080.50 | 2016 | NA | NA | View data |
| 5 |
#5
Barbados
|
2,381,725.20 | 2019 | +2.5 % | -1.6 % | View data |